A. “Harmonization of Alzheimer’s Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed),” (PAR-20-099, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-20-099.html
B. “HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional),” (RFA-AT-20-004, a reissue of RFA-AT-19-004, National Institute on Aging, in conjunction with other agencies, application deadline March 30, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AT-20-004.html
C. “Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required),” (RFA-DK-20-501, a reissue of RFA-DK-15-503, National Institute on Aging, in conjunction with other agencies, application deadline April 22, 2020). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required),” (RFA-DK-20-502).
